Balance Sheet - Detailed Explanation, Components, and Examples
September 2, 2025
TABLE OF CONTENTS
Amanta Healthcare Limited is coming with an IPO. Amanta Healthcare Limited, based in Ahmedabad, Gujarat (India), will be one of the new entrants in the Indian healthcare industry. The company is in the health care services and offers complete medical solutions across several medical segments. There are many healthcare service opportunities due to the ever-growing healthcare infrastructure in India, and some analysts are seeing the potential of the company. The IPO price for every share is ₹126, and the timing is good for people to get exposure to an investment in healthcare companies.
Currently, it is showing Amanta Healthcare IPO GMP today ₹15-20 (11.90-15.87%) premium in the grey market. Greymarket indicates the investors are willing to pay ₹15-20 more than the IPO price, indicating many investors are looking to get into the company as shares.
The Amanta Healthcare Limited IPO will open on September 1, 2025, and close on September 3, 2025. The allotment date is September 4, 2025, and listing will happen on September 9, 2025.
Details | Information |
---|---|
Company Name | Amanta Healthcare Limited |
Issue Size | ₹126.00 Cr |
Issue Type | Book Building Issue (Fresh Issue) |
Price Band | ₹126 per share |
Lot Size | 119 shares |
Face Value | ₹1 per share |
Listing On | NSE & BSE |
Expected Listing Price | ₹141-146 (Based on GMP) |
Fresh Issue | ₹126.00 Cr |
To buy Amanta Healthcare shares, you need to invest at least ₹14,994 for 119 shares. The current GMP of 11.90-15.87% shows good demand from investors. This is one of the notable IPOs in the healthcare sector this year.
Amanta Healthcare Limited is a growing healthcare company in Ahmedabad, Gujarat, India. The company started with the intention to provide quality healthcare services, and they have developed caring and reliable partners in India's healthcare development.
Amanta Healthcare is committed to meeting many of the needs for healthcare development, with the provision of complete medical solutions that are designed to be consistent with India's expanding healthcare needs. Amanta Healthcare is dedicated to performing to the utmost quality standards, and offering value-based healthcare solutions that will further aid to assist the healthcare growth of India.
The company desires to diversify its healthcare portfolio and, to date, become more visible in the markets that are available. It intends through this contemplated IPO to use the funds received to develop its business enclosure by geographically expanding, investing in new medical technology, updating its equipment, increasing its service delivery capacity, and meeting the working capital requirements to execute all plans.
MUFG Intime India Private Limited (Link Intime) is the registrar for the IPO. The company intends to utilize the proceeds from the IPO for expanding operations, upgrading medical technology and equipment, enhancing service delivery, paying off loans, and general working capital. With the continued growth of India's healthcare market, Amanta Healthcare is well-positioned for all the growth opportunities.
The company has shown mixed performance in recent years.
Year | Mar-25 | Mar-24 | Mar-23 |
---|---|---|---|
Assets (₹ Cr) | 381.76 | 352.12 | 374.06 |
Total Income (₹ Cr) | 276.09 | 281.61 | 262.7 |
Profit After Tax (₹ Cr) | 10.5 | 3.63 | -2.11 |
EBITDA (₹ Cr) | 61.05 | 58.76 | 56.31 |
Net Worth (₹ Cr) | 96.39 | 66.29 | 62.88 |
Reserves and Surplus (₹ Cr) | 67.56 | 39.46 | 36.05 |
Total Borrowing (₹ Cr) | 195 | 205.23 | 215.66 |
Amanta Healthcare had mixed results for the period of Mar 23 to Mar 25, with asset growth of 2.1% while the company increased total income by 5.1% to ₹276.09 Cr. Profit After Tax improved greatly from losses of Mar-23 (-₹2.11 Cr), to profits of ₹10.5 Cr in Mar-25, suggesting considerable operational improvement. EBITDA grew 8.4% to reach ₹61.05 Cr, indicating improved operational efficiency. Total net worth grew 53.3% to ₹96.39 Cr mainly due to profitability improvements and retained profits. Total borrowings decreased from ₹215.66 Cr to ₹195 Cr, indicating the school better debt management and financial discipline.
The shares will be divided as per SEBI rules:
Investor Type | Share % | Who Can Apply |
---|---|---|
Retail Investors | 35% | Individual investors |
HNI (High Net Worth) | 15% | Rich individuals |
QIB (Institutional) | 50% | Banks, mutual funds |
1. Robust Growth in Healthcare Market:
India's healthcare market presents very strong growth prospects, being driven by increasing health consciousness and the government’s focus on expanding healthcare infrastructure.
2. Turnaround from Losses to Profitability:
The Company has achieved a turnaround from losses, improving from a PAT of -₹2.11 Cr in FY 20/21 to a PAT of ₹10.5 Cr in FY 21/22.
3. Internal Growth & Debt Reduction:
EBITDA grew 8.4%, reflecting improved operational performance and margin improvements. During this period, the Company also achieved an overall reduction in borrowings of 9.6%.
4. Good GMP Through Investor Confidence:
The Company has an indicative GMP of 11.90–15.87% indicating reasonable investor confidence.
5. Healthcare Company:
The Company operates in the essential healthcare industry, which has continuously growing demand.
6. Strong Government Tailwinds:
The healthcare sector benefits from government initiatives and increased spending on healthcare infrastructure.
1. Revenue Drop:
Total revenue has fallen from ₹281.61 Cr to ₹276.09 Cr, showing revenue weakness.
2. Low Profitability:
Profitability is in place but still low at 3.8%.
3. Intensive Working Capital Needs:
Healthcare businesses require considerable working capital investment to operate.
4. Regulatory Scrutiny:
Healthcare companies face strict regulations and policy risks.
5. Competition:
The industry faces intense competition from both legacy players and new entrants.
6. Cyclical Nature:
Healthcare can be discretionary spending and may be impacted during down cycles.
7. Continued High Debt:
Debt was reduced, but borrowings of ₹195 Cr remain considerably high compared to the net worth.
8. Slow Payments:
Healthcare companies often face extended payment cycles from government and insurance clients.
Simple steps to apply (IPO opens September 1, 2025):
Open your trading app (Zerodha, Angel One, Groww, etc.)
Go to IPO section
Find Amanta Healthcare IPO and click Apply
Fill details:
Number of lots (minimum 1 lot = 119 shares)
Bid price (₹126 or choose Cut-Off)
Your UPI ID
Submit application
Approve UPI payment request on your phone
Important: Approve UPI payment before 5 PM on the same day or before IPO closes on September 3, 2025.
You can check allotment in two ways:
Go to NSE or BSE official website
Click on IPO section
Select Amanta Healthcare IPO
Enter your PAN number or application number
Click submit to see results
Select IPO allotment status
Choose Amanta Healthcare IPO
Enter PAN or application number
Submit to check your allotment status
Name: Amanta Healthcare Limited
Address: 8th Floor, Shaligram Corporates, C.J. Marg, Ambli, Ahmedabad, Gujarat, 380058
Phone: 079 67777600
Email: cs@amanta.co.in
Website: https://www.amanta.co.in/
Name: MUFG Intime India Private Limited (Link Intime)
Phone: +91 22 4918 6270
Email: amantahealthcare.ipo@linkintime.co.in
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Address: Link Intime India Pvt Ltd, C 101, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai - 400083
Amanta Healthcare Limited provides a mixed investment prospect, and now let's see if you can unearth the potential in a booming healthcare story in India. While there certainly have been examples to follow regarding operational turnaround to profitability and, moreover, an improvement in debt management, it is concerning that the revenue is declining and profitability is even marginally low. The share price of ₹126 is indicative of partial market excitement with a grey market premium (GMP) of 11.90-15.87% price typically indicating a mixed/medium market sentiment on the IPO.
Amanta operates in a healthcare industry that benefits from the expanding health infrastructure and increased health consciousness and awareness in India. The firm just delivered profitability after previous losses, indicating the marketing repeatedly used the jargon "management able to execute a turnaround."
Typical of an emerging, growing healthcare sector, investor risk exists around regulatory risks, competition, working capital, and the government's policies. Volatility in revenue declines even with improved profitability, raising questions about sustaining future growth.
In summary, Amanta Healthcare's improving financials and declining debt reflect improved operational management and discipline. If you're interested in assessing this IPO or looking up any other stock's financial information, ratios, or technical studies, using appropriate analysis tools will also be beneficial in deciding your next investment.
Disclaimer: This analysis is for educational purposes and not financial advice. Please consult a financial advisor before making investment decisions.
1. What is Amanta Healthcare IPO GMP today?
Amanta Healthcare IPO GMP is currently ₹15-20 (11.90-15.87% premium) in the grey market. This indicates investors are willing to pay ₹15-20 more than the IPO price of ₹126, showing positive market sentiment for the healthcare company's IPO.
2. When is Amanta Healthcare IPO listing date?
Amanta Healthcare IPO listing date is September 9, 2025. The IPO opens on September 1, 2025, closes on September 3, 2025, with allotment on September 4, 2025. Shares will be listed on both NSE and BSE exchanges.
3. How to check Amanta Healthcare IPO allotment status?
You can check Amanta Healthcare IPO allotment status on the registrar website (MUFG Intime India) at https://in.mpms.mufg.com/Initial_Offer/public-issues.html or NSE/BSE websites. Enter your PAN number or application number to check if you got shares.
4. What is the minimum investment in Amanta Healthcare IPO?
The minimum investment in Amanta Healthcare IPO is ₹14,994 for 1 lot of 119 shares at ₹126 per share. The lot size is 119 shares, so you must apply for multiples of 119 shares only.
5. What is Amanta Healthcare IPO subscription status?
Amanta Healthcare IPO subscription status will be updated during the IPO period (Sep 1-3, 2025). The subscription data shows how many times the IPO is oversubscribed across retail, HNI, and institutional investor categories.
6. Should I invest in Amanta Healthcare IPO?
Amanta Healthcare shows operational turnaround with improved profitability (₹10.5 Cr PAT vs -₹2.11 Cr loss earlier) and debt reduction. However, revenue declined slightly. Consider your risk appetite and consult a financial advisor before investing.
7. How to apply for Amanta Healthcare IPO?
To apply for Amanta Healthcare IPO, open your trading app (Zerodha, Angel One, Groww), go to IPO section, select Amanta Healthcare IPO, enter number of lots, bid price (₹126), UPI ID, and approve the UPI payment before 5 PM on application day.
Share Market
IPO
Artificial Intelligence
Semi Conductor